The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dacomitinib Tablets Market Research Report 2025
Synopsis
Single agent for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion mutations or exon 21 L858R substitution mutations.
The global Dacomitinib Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dacomitinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dacomitinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dacomitinib Tablets include Chengdu Beite Pharmaceutical and Pfizer etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dacomitinib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dacomitinib Tablets.
Report Scope
The Dacomitinib Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dacomitinib Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dacomitinib Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu Beite Pharmaceutical
Pfizer
Segment by Type
45mg
15mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dacomitinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dacomitinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Single agent for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion mutations or exon 21 L858R substitution mutations.
The global Dacomitinib Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dacomitinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dacomitinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dacomitinib Tablets include Chengdu Beite Pharmaceutical and Pfizer etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dacomitinib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dacomitinib Tablets.
Report Scope
The Dacomitinib Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dacomitinib Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dacomitinib Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu Beite Pharmaceutical
Pfizer
Segment by Type
45mg
15mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dacomitinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dacomitinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dacomitinib Tablets Market Overview
1.1 Product Overview and Scope of Dacomitinib Tablets
1.2 Dacomitinib Tablets Segment by Type
1.2.1 Global Dacomitinib Tablets Market Value Comparison by Type (2024-2030)
1.2.2 45mg
1.2.3 15mg
1.3 Dacomitinib Tablets Segment by Application
1.3.1 Global Dacomitinib Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dacomitinib Tablets Market Size Estimates and Forecasts
1.4.1 Global Dacomitinib Tablets Revenue 2019-2030
1.4.2 Global Dacomitinib Tablets Sales 2019-2030
1.4.3 Global Dacomitinib Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dacomitinib Tablets Market Competition by Manufacturers
2.1 Global Dacomitinib Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dacomitinib Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dacomitinib Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Dacomitinib Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dacomitinib Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dacomitinib Tablets, Product Type & Application
2.7 Dacomitinib Tablets Market Competitive Situation and Trends
2.7.1 Dacomitinib Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dacomitinib Tablets Players Market Share by Revenue
2.7.3 Global Dacomitinib Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dacomitinib Tablets Retrospective Market Scenario by Region
3.1 Global Dacomitinib Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dacomitinib Tablets Global Dacomitinib Tablets Sales by Region: 2019-2030
3.2.1 Global Dacomitinib Tablets Sales by Region: 2019-2024
3.2.2 Global Dacomitinib Tablets Sales by Region: 2025-2030
3.3 Global Dacomitinib Tablets Global Dacomitinib Tablets Revenue by Region: 2019-2030
3.3.1 Global Dacomitinib Tablets Revenue by Region: 2019-2024
3.3.2 Global Dacomitinib Tablets Revenue by Region: 2025-2030
3.4 North America Dacomitinib Tablets Market Facts & Figures by Country
3.4.1 North America Dacomitinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dacomitinib Tablets Sales by Country (2019-2030)
3.4.3 North America Dacomitinib Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dacomitinib Tablets Market Facts & Figures by Country
3.5.1 Europe Dacomitinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dacomitinib Tablets Sales by Country (2019-2030)
3.5.3 Europe Dacomitinib Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Dacomitinib Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Dacomitinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dacomitinib Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Dacomitinib Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Dacomitinib Tablets Market Facts & Figures by Country
3.7.1 Latin America Dacomitinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dacomitinib Tablets Sales by Country (2019-2030)
3.7.3 Latin America Dacomitinib Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dacomitinib Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dacomitinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dacomitinib Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dacomitinib Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dacomitinib Tablets Sales by Type (2019-2030)
4.1.1 Global Dacomitinib Tablets Sales by Type (2019-2024)
4.1.2 Global Dacomitinib Tablets Sales by Type (2025-2030)
4.1.3 Global Dacomitinib Tablets Sales Market Share by Type (2019-2030)
4.2 Global Dacomitinib Tablets Revenue by Type (2019-2030)
4.2.1 Global Dacomitinib Tablets Revenue by Type (2019-2024)
4.2.2 Global Dacomitinib Tablets Revenue by Type (2025-2030)
4.2.3 Global Dacomitinib Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Dacomitinib Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dacomitinib Tablets Sales by Application (2019-2030)
5.1.1 Global Dacomitinib Tablets Sales by Application (2019-2024)
5.1.2 Global Dacomitinib Tablets Sales by Application (2025-2030)
5.1.3 Global Dacomitinib Tablets Sales Market Share by Application (2019-2030)
5.2 Global Dacomitinib Tablets Revenue by Application (2019-2030)
5.2.1 Global Dacomitinib Tablets Revenue by Application (2019-2024)
5.2.2 Global Dacomitinib Tablets Revenue by Application (2025-2030)
5.2.3 Global Dacomitinib Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Dacomitinib Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chengdu Beite Pharmaceutical
6.1.1 Chengdu Beite Pharmaceutical Corporation Information
6.1.2 Chengdu Beite Pharmaceutical Description and Business Overview
6.1.3 Chengdu Beite Pharmaceutical Dacomitinib Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chengdu Beite Pharmaceutical Dacomitinib Tablets Product Portfolio
6.1.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Dacomitinib Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Dacomitinib Tablets Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dacomitinib Tablets Industry Chain Analysis
7.2 Dacomitinib Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dacomitinib Tablets Production Mode & Process
7.4 Dacomitinib Tablets Sales and Marketing
7.4.1 Dacomitinib Tablets Sales Channels
7.4.2 Dacomitinib Tablets Distributors
7.5 Dacomitinib Tablets Customers
8 Dacomitinib Tablets Market Dynamics
8.1 Dacomitinib Tablets Industry Trends
8.2 Dacomitinib Tablets Market Drivers
8.3 Dacomitinib Tablets Market Challenges
8.4 Dacomitinib Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
